Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H37NO2 |
| Molecular Weight | 395.5775 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 4 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NC1=CC=C(O)C=C1
InChI
InChIKey=IJBZOOZRAXHERC-DOFZRALJSA-N
InChI=1S/C26H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-26(29)27-24-20-22-25(28)23-21-24/h6-7,9-10,12-13,15-16,20-23,28H,2-5,8,11,14,17-19H2,1H3,(H,27,29)/b7-6-,10-9-,13-12-,16-15-
| Molecular Formula | C26H37NO2 |
| Molecular Weight | 395.5775 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 4 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. | 2008-06-11 |
|
| The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events. | 2007-04-01 |
|
| Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. | 2005-03 |
|
| Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. | 2003-03 |
|
| The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. | 2001-04-20 |
|
| The anandamide transport inhibitor AM404 activates vanilloid receptors. | 2000-05-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:10:03 GMT 2025
by
admin
on
Mon Mar 31 22:10:03 GMT 2025
|
| Record UNII |
XVJ94H0U21
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
183718-77-6
Created by
admin on Mon Mar 31 22:10:03 GMT 2025 , Edited by admin on Mon Mar 31 22:10:03 GMT 2025
|
PRIMARY | |||
|
6604822
Created by
admin on Mon Mar 31 22:10:03 GMT 2025 , Edited by admin on Mon Mar 31 22:10:03 GMT 2025
|
PRIMARY | |||
|
AM404
Created by
admin on Mon Mar 31 22:10:03 GMT 2025 , Edited by admin on Mon Mar 31 22:10:03 GMT 2025
|
PRIMARY | |||
|
XVJ94H0U21
Created by
admin on Mon Mar 31 22:10:03 GMT 2025 , Edited by admin on Mon Mar 31 22:10:03 GMT 2025
|
PRIMARY | |||
|
DTXSID60424985
Created by
admin on Mon Mar 31 22:10:03 GMT 2025 , Edited by admin on Mon Mar 31 22:10:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> ACTIVATOR |
Inhibits a anandamide selective transport mechanism (reuptake)
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
